Day: August 22, 2024

SECOND-QUARTER RESULTS The continuing Danish activities showed sustained profitable growth in the second quarter, following stable production and order book execution. Earnings were improved, and the order intake showed a rising trend. With the divestment of Seth, MT Højgaard Holding exited Portugal and Africa, and in the winding up of the international activities, Greenland is the only outstanding item.Revenue was up by 8% to DKK 2.7 billion. Growth was driven in particular by MT Højgaard Danmark. Operating profit (EBIT) rose by 49% to DKK 124 million, and the operating margin rose from 3.4% to 4.7%. The continuing Danish activities improved the after-tax profit from DKK 55 million to DKK 81 million. The DKK 29 million loss from discontinued operations was due in particular to costs of winding up the activities in Greenland. The loss...

COPENHAGEN, Denmark, August 22, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first half of 2024 and released its financial calendar for 2025.Revenue for the first half was DKK 2,259 million, and the operating profit (EBITDA) was DKK 441 million. Revenue from travel health increased by 15% to DKK 1,119 million and revenue from public preparedness was DKK 1,024 million, which is in line with the Company’s expectations. Other revenue was DKK 116 million. Revenues from Rabipur/RabAvert and Encepur have reached levels exceeding the original expectations at the time of acquisition, thus triggering a sales milestone of DKK 186 million to GSK, payable in the third quarter of 2024. Bavarian Nordic confirms its new guidance for the full year at the upper end of the range, with...

                                                        Press release – regulated informationContinued progress in regulatory review of its first candidate biofungicide EVOCA™* Dutch Authority CTGB approved large scale demonstration trials with EVOCA while allowing sale of harvest Commenced field trials for second biofungicide to expand potential product line Initiated an AI project with Google DeepMind and Devoteam using AlphaFold2 Cash and cash equivalents amounted to €14.7 million as of the end of June 2024 Management to host a conference call and live webcast at 15:00 CEST / 14:00 GMT / 09:00 AM ET today, details belowGhent, BELGIUM, Aug. 22, 2024 (GLOBE NEWSWIRE) —  Biotalys (Euronext – BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrols for sustainable crop protection,...

Hollywood strike weighs on Kinepolis’ visitor numbers in first half of 2024, but line-up for the rest of the year is promising Regulatory release 22 August 2024, 7:00 am CET Kinepolis had a challenging first half of the year, as expected, with fewer visitors due to a poor blockbuster offering. Last year’s long strike in Hollywood prevented a return to the rich film offering from before the pandemic, but improvement is heralded. Since June, a turnaround has begun thanks to the success of ‘Inside Out 2’ and ‘Deadpool & Wolverine’, among others, and numerous big releases are planned in the autumn, including the highly anticipated ‘Joker: Folie à Deux’, ‘Gladiator II’ and ‘Moana 2’. Revenue, EBITDA, EBITDAL and profit decreased in the first half compared to the same period...

The Hague, August 22, 2024 – Please click here to access all 1H 2024 results related documents. IFRS resultsNet loss of EUR 65 million with operating result more than offset by fair value losses in the US and the impact of assumption updates Operating result decreases by 8% compared with the first half of 2023 to EUR 750 million, reflecting unfavorable mortality experience mainly related to US Financial Assets Shareholders’ equity per share decreases by 6% compared with December 31, 2023 to EUR 4.02, while CSM per share after estimated tax adjustment increases by 14% to EUR 4.17Capital generation, cash and capital managementOperating capital generation before holding funding and operating expenses decreases by 5% compared with the first half of 2023 to EUR 588 million reflecting unfavorable mortality experience in the US,...

STEADY COURSE – SOLID RESULTS AND CONTINUED DIVIDEND HIGHLIGHTS EBITDA of USD 29.3m including USD 2.9m from operating business Net result of USD 18.9m   Declared dividend of NOK 0.55 per share Sold two debt-free Supramax vessels (2016-built) for a total of USD 56.6m Declared purchase option for BELMAR (2021-built) for a price of USD 25.5m Acquired 2024-built Ultramax bulk carrier for USD 41m to be delivered in Q1 2025 Expanded newbuilding program with two new leased vessels in 2027 and 2028 Extended and amended bank financing on improved terms – new maturity Q2 2029 TCE of USD 16 982 gross per day for owned fleet 83 per cent of ship days in Q3 2024 are fixed at USD 16 800 gross per day 41 per cent of ship days in the next four quarters are fixed at USD 16 650 gross per day Cash breakeven for 2024 of about USD 10 900 per day per vessel Uniform...

 HighlightsGN executed strongly across the three divisions resulting in 5% organic revenue growth for the Group The Hearing division continued to gain significant market share leading to 10% organic revenue growth, resulting in 5.3 percentage point increase in the divisional profit margin supported by synergies and the successful ReSound Nexia roll-out The Enterprise division continued its focused execution leading to -3% organic revenue growth in a stabilizing market. The divisional profit margin increased by 1.3 percentage points driven by synergies, product mix, and strict cost control The Gaming & Consumer division delivered organic revenue growth of 12% following strong execution in Gaming. The decision to gradually wind-down Elite and Talk product lines resulted as planned in increased promotional activities towards the end...